(BOTZ) Global X Robotics - Ratings and Ratios
Robotics, Artificial Intelligence, Automation, Industrial Machinery
Dividends
| Dividend Yield | 0.22% |
| Yield on Cost 5y | 0.25% |
| Yield CAGR 5y | -9.46% |
| Payout Consistency | 80.4% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 23.2% |
| Value at Risk 5%th | 39.3% |
| Relative Tail Risk | 2.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.20 |
| Alpha | -13.07 |
| CAGR/Max DD | 0.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.420 |
| Beta | 1.245 |
| Beta Downside | 1.146 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.02% |
| Mean DD | 6.37% |
| Median DD | 4.60% |
Description: BOTZ Global X Robotics November 09, 2025
The Global X Robotics & Artificial Intelligence ETF (NASDAQ: BOTZ) allocates at least 80 % of its assets to securities that track the Indxx Robotics & Artificial Intelligence Index, giving investors exposure to exchange-listed companies in developed markets that develop robotics and AI technologies. The fund is classified as a “Miscellaneous Sector” ETF, originates from the United States, and is designated as non-diversified under SEC rules.
Key metrics that investors often monitor include its expense ratio of 0.68 % and a concentrated top-10 holding list-currently dominated by firms such as Nvidia (NVDA), Intuitive Surgical (ISRG), and Keyence (6861 JP)-which together account for roughly 30 % of assets. The robotics and AI market is projected to grow at a compound annual growth rate of about 26 % through 2027, driven by expanding industrial automation, rising demand for AI-enabled healthcare devices, and increasing adoption of autonomous systems in logistics.
For a deeper, data-driven look at BOTZ’s risk-adjusted performance and sector exposure, you may find it useful to explore the analytical tools available on ValueRay.
What is the price of BOTZ shares?
Over the past week, the price has changed by +5.02%, over one month by -7.59%, over three months by +3.23% and over the past year by +5.65%.
Is BOTZ a buy, sell or hold?
What are the forecasts/targets for the BOTZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.4 | 0.6% |
BOTZ Fundamental Data Overview November 24, 2025
Beta = 1.47
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.85b USD (2.85b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.85b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.85b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.60% (E(2.85b)/V(2.85b) * Re(10.60%) + (debt-free company))
Discount Rate = 10.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BOTZ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle